|
Feb 1
|
No One Knows How to Price AI Tools
|
|
Feb 1
|
Why Bristol-Myers Squibb Company (BMY) Is Among the Best Long Term Low Risk Stocks to Buy Now
|
|
Jan 31
|
Top Dividend Stocks Yielding As High As 5%: Fidelity
|
|
Jan 31
|
Stocks to watch next week: Amazon, Palantir, Disney, Novo Nordisk and AstraZeneca
|
|
Jan 31
|
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
|
|
Jan 31
|
Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a First-Line Treatment Option for Adult Patients with Unresectable or Advanced Hepatocellular Carcinoma
|
|
Jan 31
|
Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma
|
|
Jan 30
|
Will Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report?
|
|
Jan 30
|
Bristol Myers Squibb (BMY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
Jan 30
|
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
|
|
Jan 30
|
Why Bristol-Myers Squibb Company (BMY) Is the Best Blue Chip Stock to Buy Under $100?
|
|
Jan 29
|
Bristol-Myers Squibb (BMY): Cramer’s Old-School Move for DeepSeek Market Jitters
|
|
Jan 29
|
Bristol-Myers Squibb Insider Ups Holding During Year
|
|
Jan 29
|
3 Cheap Dividend Stocks That Pay More Than Double the S&P 500 Average
|
|
Jan 29
|
Is Bristol-Myers Squibb Company (BMY) the Safe Stock to Buy for the Long Term in 2025?
|
|
Jan 28
|
Drugmakers Show Restraint on Price Increases in New Trump Era
|
|
Jan 27
|
Why the Market Dipped But Bristol Myers Squibb (BMY) Gained Today
|
|
Jan 27
|
Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know
|
|
Jan 20
|
Bristol-Myers Squibb Company (BMY): A Bull Case Theory
|
|
Jan 18
|
Why Bristol-Myers Squibb (BMY) Is One of the Best Cheap Stocks to Buy for 2025?
|